首页 | 本学科首页   官方微博 | 高级检索  
     

爱维治治疗前部缺血性视神经病变的疗效观察
引用本文:王兰惠,魏景文,种泽龙,韩梅. 爱维治治疗前部缺血性视神经病变的疗效观察[J]. 中华眼底病杂志, 2006, 22(2): 97-99
作者姓名:王兰惠  魏景文  种泽龙  韩梅
作者单位:300020,天津市眼科医院
摘    要:
目的 观察爱维治治疗前部缺血性视神经病变(AION)的疗效。 方法 临床确诊的AION患者58例60只眼,其中29例30只眼接受爱维治1200 mg/d静脉滴注治疗(治疗组);另外29例30只眼接受1~2种溶栓抗凝剂或血管扩张剂1次/d静脉滴注治疗(对照组)。均以15 d为1个疗程。对照组中20只眼还同时进行眼局部药物注射,包括糖皮质激素、654-2球后或球旁注射,1次/d或1次/2 d,用药3~5次。两组患者用药后每天观察视力、眼底变化,治疗前有视野检查者复查视野。 结果 治疗组视力提高程度明显好于对照组,两组间差异有统计学意义(t=2.74, P<0.01); 用药第3天,两组视力提高程度差异无统计学意义(t=1.34, P>0.05); 第5、10、15天,治疗组视力提高程度明显好于对照组,其差异有统计学意义(t=2.01, P<0.05; t=2.07, P<0.05; t=2.74, P<0.01);治疗组有视野检查的15只眼中,13只眼治疗后视野好转,占87.00%;2只眼无变化,占13.00%。对照组有视野检查的13只眼中,4只眼治疗后视野好转,占31.00%;9只眼无变化,占69.00%。两组视野变化的差异比较有统计学意义(χ2=9.66,P<0.01)。 结论 爱维治治疗AION有效。 (中华眼底病杂志, 2006, 22: 97-99)

关 键 词:视神经疾病/药物疗法 爱维治/治疗应用
收稿时间:2004-10-26
修稿时间:2004-10-26

Therapeutic effect of ai-weizhi on anterior ischmic optic neuropathy
WANG Lan-hui,WEI Jing-wen,ZHONG Ze-long,et al. Therapeutic effect of ai-weizhi on anterior ischmic optic neuropathy[J]. Chinese Journal of Ocular Fundus Diseases, 2006, 22(2): 97-99
Authors:WANG Lan-hui  WEI Jing-wen  ZHONG Ze-long  et al
Affiliation:Tianjin Eye Hospital, Tianjin 300020, China
Abstract:
Objective To observe the therapeutic effect of ai-weizhi on anterior ischmic optic neuropathy (AION). Methods In 58 patients (60 eyes) who were diagnosed as with AION, 29 patients (30 eyes) underwent intravenous drip with ai-weizhi (1200 mg/d) (treatment group), and the other 29 patients (30 eyes) underwent intravenous drip with 1-2 kinds of thrombolytic coagulant or vasodilator (once per day) (control group) with the period of treatment of 15 days. In the control group, ocular local injection, including gluco-corticosteroid and 654-2 behind or beside the eyeball injected once per day or every 2 days for 3-5 times, was perfomed on 20 eyes simultaneously. The changes of visual acuity and ocular fundus of the patients after injection were recorded, and the visual field was counterchecked in the patients who had underwent the examination before the treatment. Results The visual acuity was better in treatment group than which in control group with a significant difference (t=2.74, P<0.01). The visual acuity in treatment group didn′t differ much from which in the control group 3 days after treatment (t=1.34, P>0.05). At the 5th、10th and 15th day after treatment, the visual acuity was better in treatment group than which in control group with a significant difference(t=2.01, P<0.05; t=2.07, P<0.05;t=2.74, P<0.01). In 15 eyes in control group which had undergone examination of visual field, the visual field improved in 13 (87.00%) and of remained still in 2 (13.00%). In 13 eyes in treatment group which had undergone examination of visual field, the visual field improved in 4 (31.00%) and remained still in 9 (69.00%). There was a significant difference between the two groups (χ2=9.66, P<0.01). Conclusion Ai-weizhi is efficacious in treatment of AION. (Chin J Ocul Fundus Dis, 2006, 22: 97-99)
Keywords:Diseases of optic nerve/drug therapy   Ai-weizhi/treatment and application
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中华眼底病杂志》浏览原始摘要信息
点击此处可从《中华眼底病杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号